{"id":9675,"date":"2025-05-29T13:42:02","date_gmt":"2025-05-29T11:42:02","guid":{"rendered":"https:\/\/shams-alyaoum.com\/en\/?p=9675"},"modified":"2025-05-29T13:42:03","modified_gmt":"2025-05-29T11:42:03","slug":"fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable","status":"publish","type":"post","link":"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/","title":{"rendered":"Fitch upgrades Hikma Pharmaceuticals PLC\u2019s long-term issuer default rating to \u2018BBB\u2019, outlook stable"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Hikma Pharmaceuticals PLC (Hikma, Company) is pleased to announce that Fitch has upgraded its long-term issuer default rating and the senior unsecured rating on Hikma Finance USA LLC\u2019s $500 million notes to \u2018BBB\u2019 from \u2018BBB-\u2018 with a stable outlook.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Khalid Nabilsi, CFO of Hikma said:<\/strong>&nbsp;\u201cI am pleased that now both Fitch and S&amp;P have upgraded Hikma to BBB, reinforcing our investment grade rating. These upgrades are a strong endorsement of our strategic direction, financial discipline, and operational resilience. They underscore Hikma\u2019s solid market position across key geographies and reflect confidence in our ability to consistently deliver strong financial results, supported by our diversified business model, robust balance sheet, and prudent capital allocation.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hikma Pharmaceuticals PLC (Hikma, Company) is pleased to announce that Fitch has upgraded its long-term issuer default rating and the senior unsecured rating on Hikma Finance USA LLC\u2019s $500 million notes to \u2018BBB\u2019 from \u2018BBB-\u2018 with a stable outlook. Khalid Nabilsi, CFO of Hikma said:&nbsp;\u201cI am pleased that now both Fitch and S&amp;P have upgraded &hellip;<\/p>\n","protected":false},"author":2,"featured_media":9676,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[9,1310,1392],"class_list":["post-9675","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-business","tag-general","tag-health"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Fitch upgrades Hikma Pharmaceuticals PLC\u2019s long-term issuer default rating to \u2018BBB\u2019, outlook stable - Magazine Shams Al Yaoum<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fitch upgrades Hikma Pharmaceuticals PLC\u2019s long-term issuer default rating to \u2018BBB\u2019, outlook stable - Magazine Shams Al Yaoum\" \/>\n<meta property=\"og:description\" content=\"Hikma Pharmaceuticals PLC (Hikma, Company) is pleased to announce that Fitch has upgraded its long-term issuer default rating and the senior unsecured rating on Hikma Finance USA LLC\u2019s $500 million notes to \u2018BBB\u2019 from \u2018BBB-\u2018 with a stable outlook. Khalid Nabilsi, CFO of Hikma said:&nbsp;\u201cI am pleased that now both Fitch and S&amp;P have upgraded &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/\" \/>\n<meta property=\"og:site_name\" content=\"Magazine Shams Al Yaoum\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-29T11:42:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-29T11:42:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2025\/05\/Hikma-LOGO_1745483450-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"666\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"shamsalyaoum\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"shamsalyaoum\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/\",\"url\":\"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/\",\"name\":\"Fitch upgrades Hikma Pharmaceuticals PLC\u2019s long-term issuer default rating to \u2018BBB\u2019, outlook stable - Magazine Shams Al Yaoum\",\"isPartOf\":{\"@id\":\"https:\/\/shams-alyaoum.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2025\/05\/Hikma-LOGO_1745483450-1.jpg\",\"datePublished\":\"2025-05-29T11:42:02+00:00\",\"dateModified\":\"2025-05-29T11:42:03+00:00\",\"author\":{\"@id\":\"https:\/\/shams-alyaoum.com\/en\/#\/schema\/person\/6e4dae56c61a28d2d84c342a9a53d199\"},\"breadcrumb\":{\"@id\":\"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/#primaryimage\",\"url\":\"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2025\/05\/Hikma-LOGO_1745483450-1.jpg\",\"contentUrl\":\"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2025\/05\/Hikma-LOGO_1745483450-1.jpg\",\"width\":1000,\"height\":666},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/shams-alyaoum.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fitch upgrades Hikma Pharmaceuticals PLC\u2019s long-term issuer default rating to \u2018BBB\u2019, outlook stable\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/shams-alyaoum.com\/en\/#website\",\"url\":\"https:\/\/shams-alyaoum.com\/en\/\",\"name\":\"Magazine Shams Al Yaoum\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/shams-alyaoum.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/shams-alyaoum.com\/en\/#\/schema\/person\/6e4dae56c61a28d2d84c342a9a53d199\",\"name\":\"shamsalyaoum\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/shams-alyaoum.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11774fd6260846ea4d3230345b47c868eaffb0fe76386b1a8b3cc24c8dc91f3d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11774fd6260846ea4d3230345b47c868eaffb0fe76386b1a8b3cc24c8dc91f3d?s=96&d=mm&r=g\",\"caption\":\"shamsalyaoum\"},\"url\":\"https:\/\/shams-alyaoum.com\/en\/author\/shamsalyaoum\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fitch upgrades Hikma Pharmaceuticals PLC\u2019s long-term issuer default rating to \u2018BBB\u2019, outlook stable - Magazine Shams Al Yaoum","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/","og_locale":"en_US","og_type":"article","og_title":"Fitch upgrades Hikma Pharmaceuticals PLC\u2019s long-term issuer default rating to \u2018BBB\u2019, outlook stable - Magazine Shams Al Yaoum","og_description":"Hikma Pharmaceuticals PLC (Hikma, Company) is pleased to announce that Fitch has upgraded its long-term issuer default rating and the senior unsecured rating on Hikma Finance USA LLC\u2019s $500 million notes to \u2018BBB\u2019 from \u2018BBB-\u2018 with a stable outlook. Khalid Nabilsi, CFO of Hikma said:&nbsp;\u201cI am pleased that now both Fitch and S&amp;P have upgraded &hellip;","og_url":"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/","og_site_name":"Magazine Shams Al Yaoum","article_published_time":"2025-05-29T11:42:02+00:00","article_modified_time":"2025-05-29T11:42:03+00:00","og_image":[{"width":1000,"height":666,"url":"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2025\/05\/Hikma-LOGO_1745483450-1.jpg","type":"image\/jpeg"}],"author":"shamsalyaoum","twitter_card":"summary_large_image","twitter_misc":{"Written by":"shamsalyaoum","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/","url":"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/","name":"Fitch upgrades Hikma Pharmaceuticals PLC\u2019s long-term issuer default rating to \u2018BBB\u2019, outlook stable - Magazine Shams Al Yaoum","isPartOf":{"@id":"https:\/\/shams-alyaoum.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/#primaryimage"},"image":{"@id":"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/#primaryimage"},"thumbnailUrl":"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2025\/05\/Hikma-LOGO_1745483450-1.jpg","datePublished":"2025-05-29T11:42:02+00:00","dateModified":"2025-05-29T11:42:03+00:00","author":{"@id":"https:\/\/shams-alyaoum.com\/en\/#\/schema\/person\/6e4dae56c61a28d2d84c342a9a53d199"},"breadcrumb":{"@id":"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/#primaryimage","url":"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2025\/05\/Hikma-LOGO_1745483450-1.jpg","contentUrl":"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2025\/05\/Hikma-LOGO_1745483450-1.jpg","width":1000,"height":666},{"@type":"BreadcrumbList","@id":"https:\/\/shams-alyaoum.com\/en\/fitch-upgrades-hikma-pharmaceuticals-plcs-long-term-issuer-default-rating-to-bbb-outlook-stable\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/shams-alyaoum.com\/en\/"},{"@type":"ListItem","position":2,"name":"Fitch upgrades Hikma Pharmaceuticals PLC\u2019s long-term issuer default rating to \u2018BBB\u2019, outlook stable"}]},{"@type":"WebSite","@id":"https:\/\/shams-alyaoum.com\/en\/#website","url":"https:\/\/shams-alyaoum.com\/en\/","name":"Magazine Shams Al Yaoum","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/shams-alyaoum.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/shams-alyaoum.com\/en\/#\/schema\/person\/6e4dae56c61a28d2d84c342a9a53d199","name":"shamsalyaoum","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/shams-alyaoum.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11774fd6260846ea4d3230345b47c868eaffb0fe76386b1a8b3cc24c8dc91f3d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11774fd6260846ea4d3230345b47c868eaffb0fe76386b1a8b3cc24c8dc91f3d?s=96&d=mm&r=g","caption":"shamsalyaoum"},"url":"https:\/\/shams-alyaoum.com\/en\/author\/shamsalyaoum\/"}]}},"_links":{"self":[{"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/posts\/9675","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/comments?post=9675"}],"version-history":[{"count":1,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/posts\/9675\/revisions"}],"predecessor-version":[{"id":9677,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/posts\/9675\/revisions\/9677"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/media\/9676"}],"wp:attachment":[{"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/media?parent=9675"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/categories?post=9675"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/tags?post=9675"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}